期刊文献+

霉酚酸酯与环磷酰胺冲击疗法在狼疮性肾炎诱导治疗中的对照研究 被引量:6

Comparison between mycophenolate mofetil and cyclophosphamide pulse therapy in induction treatment of active lupus nephritis
下载PDF
导出
摘要 目的 :比较新型免疫抑制剂霉酚酸酯 (MMF)与间断性环磷酰胺 (CTX)静脉冲击疗法对活动性狼疮肾炎 (L N)的诱导治疗效果及不良反应发生情况。方法 :2 7例活动性 L N患者分两组 ,12例予 MMF 1.0~ 1.5 g/ d为口服治疗 (MMF组 ) ,15例行间断性 CTX冲击治疗 (0 .75~ 1.0 g/ m2 ,CTX组 ) ,两组均联合服用泼尼松。两组治疗前一般情况相似 ,治疗期 6个月 ,随访相关指标并监测伴随的不良反应 ,部分患者作重复肾活检。结果 :两组患者治疗后全身狼疮活动均明显受到控制。 MMF组在尿蛋白下降、贫血改善、肾功能改善及抑制自身抗体程度方面均比 CTX组更为明显。 MMF组中 9例重复肾活检示肾脏病理均有明显改善 ,CTX组中有 2例重复肾活检示肾脏病理改善不佳。MMF组不良反应发生率明显低于 CTX组。结论 :MMF联合激素在 L N诱导治疗中比 CTX冲击联合激素疗效更为突出 ,且伴随的不良反应较少。 Objective:To compare the efficacy of mycophenolate mofetil (MMF) and cyclophosphamide (CTX) pulse therapy in induction treatment of active lupus nephritis (LN). Methods:Twenty seven LN patients were included. Twelve patients were given MMF at a dose of 1.0 1.5 g/d orally(MMF group). The other 15 patients matched with age, sex and severity of renal damage were given CTX (0.75 1.0 g/m 2 body surface area) monthly for 6 months(CTX group).Both groups were supplemented with oral prednisone. The renal biopsy, blood and urinary routine, hepatic and renal function, 24 h urinary protein excretion, creatinine clearance(Ccr), anti dsDNA antibody titer, antinuclear antibody, serum complement C 3, immunoglobulin G and associated adverse effect were observed before and after treatment in both groups. Results:The SLE DAI, proteinuria, hematuria, anti dsDNA antibody titer and lower serum complement C 3 level were significantly improved in both groups after treatment ( P <0.05). Urinary protein excretion and anti dsDNA antibody titer in MMF group were lower than that of CTX group after treatment( P <0.05). Ccr and anemia were improved obviously in MMF group ( P <0.05), but changed slightly in CTX group( P >0.05).Nine patients in MMF group and 2 in CTX group had repeat renal biopsy. The active index and renal immune complex deposition decreased dramatically after given MMF, but the chronic index had no significant difference after treatment.There was no obvious improvement in CTX group.The incidence of complications was slighter in MMF group. Conclusion:MMF is more effective than CTX pulse therapy in the induction treatment of active LN, and with lower adverse effect.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2002年第6期652-655,共4页 Academic Journal of Second Military Medical University
关键词 霉酚酸酯 环磷酰胺 冲击疗法 狼疮性肾炎 诱导治疗 对照研究 mycophenolate mofetil cyclophosphamide lupus nephritis
  • 相关文献

参考文献1

二级参考文献4

共引文献97

同被引文献36

  • 1张磊,周艳丽,刘维.白芍总苷联合雷公藤多苷治疗类风湿关节炎增效减毒临床疗效观察[J].天津中医药,2005,22(3):207-208. 被引量:29
  • 2李家泰主编.临床药理学.3版.北京:人民卫生出版社,2007:541-2.
  • 3陈小红.免疫抑制剂在皮肤科的应用[J].国外医学:皮肤性病学分册,1999,25(3):184-185.
  • 4Fu LW, Yang LY, Chen WP, et al. Clinical efficacy of eyclosporine A neural in the treatment of paediatric lupus nephritis with heavy proteinuria. Br J Rheum,1998,37(2) :217-221.
  • 5Levy GD, Munz SJ, Paschal J, et al. Incidence of hydroxychloroquine retinopathy in 1207 patients in a large multicenter outpatient practice. Arthritis Rheum, 1997,40 (8) : 1482-1486.
  • 6William AB, Michael JC, Paul JS. Successful mycophenolate mofetil treatment of glomerular disease[J]. Am J Kidney Dis,1998,31 (2), 213-217.
  • 7Tafar TH, Schmid CH, Landa M, et al. Angiotensin - converting enzyme inhibitors and progression of nondiabetic renal disease. A meta- analysis of patients - level data. Ann Intern Med, 2001,135:73-87
  • 8Lewis E J, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotension - receptor antagonist irbesartan in patients with nephropathy duo to type 2 diabetes. N Engl J Med, 2001,345:851-860
  • 9Weening JJ, DAgati V, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol, 2004, 15:241-256
  • 10Nakao N, Yoshimura A, Morrita H, et al. Combination treatment of angiotensin - Ⅱ receptor blocker and angiotension - converting -enzyme inhibitor in non - diabetic renal disease (COOPERATE): a randomized controlled trial. Lancet, 2003, 361:117 -124

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部